Chargement en cours...
Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) serve as the standard of care for the first-line treatment of patients with lung cancers with EGFR-activating mutations. However, the acquisition of resistance to EGFR TKIs is almost inevitable, with extremely rare exceptions,...
Enregistré dans:
| Publié dans: | Cells |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8306990/ https://ncbi.nlm.nih.gov/pubmed/34202566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10071590 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|